Stay updated on Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page.

Latest updates to the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision entry 'Revision: v3.6.3' was added to the Record History, replacing the previous 'Revision: v3.6.2'. This reflects a newer system release for the page history.SummaryDifference0.1%

- Check19 days agoChange DetectedA new revision entry labeled v3.6.2 was added to the history and the previous revision v3.6.0 was removed from the visible history, updating the record of the study's release notes.SummaryDifference0.1%

- Check34 days agoChange DetectedUpdates to the study record history page include a new Revision: v3.6.0 and removal of the previous v3.5.5 label. In addition, the page now presents a 'Check who can join' option and a 'Find Contact Information' link to assist potential participants in assessing eligibility and contacting the study team.SummaryDifference0.5%

- Check41 days agoChange DetectedThe study history now marks SPARTAN as Recruiting and updates the page to reflect current enrollment. It also adds key sections such as Contacts/Locations, Eligibility, Study Design, Study Description, Study Status, Study Identification, and Recruitment Status, replacing the older 'Active, not recruiting' label and the previous trial title wording.SummaryDifference1%

- Check62 days agoChange DetectedA new revision entry v3.5.4 is added to the record history, updating the study's version history. The previous revision v3.5.3 is removed from the list.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page’s footer updates the ClinicalTrials.gov build/release revision from **v3.5.2** to **v3.5.3**, indicating a web/version update. No study-specific content or record-history details are altered.SummaryDifference0.1%

Stay in the know with updates to Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page.